집먼지진드기 면역요법 후 천식이 소실된 성인 천식 환자들의 임상적 특성

참고문헌 (38)

1. "Immunotherapy--state of the art", pp.249~54
2. "Efect of rush imunotherapy on airway inflamation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma", 102, pp.927~734 (1998)
3. "Effect of specific immunotherapy with house dust mite extract on the bronchial responsiveness of paediatric asthma patients", 29, pp.176~181 (1999)
4. "Allergic rhinitis and its impact on asthma update: allergen immunotherapy", 119, pp.881~891 (2007)
5. "Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study", 37, pp.1277~1285 (2007)
6. "Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study", 23, pp.2503~2506 (2007)
7. "Prevention of new sensitizations by specific im-munotherapy in children with rhinitis and", or asthma monosensitized to house dust mite, 2007, pp.17, 85~91
8. "Specific immunotherapy is effective in the prevention of new sensitivities", 35, pp.44~51 (2007)
9. "A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients", 61, pp.191~71 (2006)
10. "S t e r o i d - s p a r i n g effect of subcutaneous SQ-standardised specific immunotherapy in moderate and severe house dust mite allergic asthmatics", 61, pp.843~848 (2006)
11. "Folow-up study for symptomatic and laboratory change in bronchial asthma on immunotherapy", pp.40~5
12. "Changes of skin reactivity in asthmatics with immunotherapy", pp.15~21
13. "Changes of specific IgE, bronchial hypereactivity and sinusitis after immunotherapy in asthmatic children", 19, pp.152~621 (1999)
14. "P a r a m e t e r s i n i m -munotherapy of childhood asthma", pp.427~36
15. "Alergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability", 33, pp.52~71 (2003)
16. "B r o n c h i a l p r o v o c a t i o n t e s t i s t h e m o s t optimal termination-index of imunotherapy in extrinsic bronchial asthmatics", pp.215~28
17. "Standards for the diagnosis and c a r e o f p a t i e n t s w i t h c h r o n ic obstructive pulmonary disease This official statement of the American Thoracic Society was adopted by the ATS Board of Directors", pp.225~44
18. "Guidelines for methacholine and exercise chalenge testing-1999 This official statement of the American Thoracic Society was adopted by the ATS Board of Directors July 1999", 161, pp.309~329 (2000)
19. "Current mite, cat, and dog alergen exposure, pet ownership, and sensitization to inhalant alergens in adults", 111, pp.402~407 (2003)
20. "Prevalence of asthma and atopy in children living in rural areas of Cheju island for an interval of thre years", 22, pp.85~91 (2002)
21. "The sensitization rate to house dust mites and the prevalence of asthma in healthy young women", 24, pp.103~109 (2004)
22. "Distinct efect of sensitization of house dust mite and citrus red mite (Panonychus citri) in the development of allergic diseases in 16-18 year old adolescents living in rural areas of Jeju island", 22, pp.92~9262 (2002)
23. "Distribution of allergens in children with different atopic disorders in central Taiwan", 47, pp.127~134 (2006)
24. "Mechanisms of alergen-specific imuno-therapy", 119, pp.780~912 (2007)
25. "C D 2 5 + T c e l s a n d r e g u l a t i o n o f allergen-induced responses", 5, pp.35~412 (2005)
26. "Increased expression of allergen-induced in vitro interleukin-10 and interleukin-18 mRNA in peripheral blood monuclear cells of allergic rhinitis patients after specific immunotherapy", 34, pp.413~419 (2004)
27. "The efect of house dust mite conventional immunotherapy on the production of IL-4 and interferon-γ from t h e p e r i p h e r a l b l o d T c e l s i n a s t h m a t i c c h i l d r e n", 20, pp.741~748 (2000)
28. "Diferences in alergen-specific Th and Tc cel responses between pre-and post-immunotherapy asthmatics", 19, pp.656~665 (1999)
29. "E f i c a c y o f s u b l i n g u a l imunotherapy in patients with rhinitis and asthma due to house dust mite", alergol immu(pathol), pp.277~84 (1990)
30. "Noninjection routes for imuno-therapy", 111, pp.437~448 (2003)
31. "I m u n o l o g i c a l mechanisms of sublingual immunotherapy", 61, pp.11~14 (2006)
32. "Imune mechanisms of alergen-specific sublingual imuno-therapy", 61, pp.151~165 (2006)
33. "E f i c a c y a n d s a f e t y o f s u b l i n g u a l i m u n o t h e r a p y", 93(3-12), pp.103~ (2004)
34. "Benefits of imunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study", 57, pp.785~790 (2002)
35. "Specific imunotherapy with a standardized Dermatophagoides pteronyssinus extract Prediction of efficacy of imunotherapy", pp.971~7
36. "Recomendations for standardi-zation of clinical trials with Allergen Specific Imunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce", 62, pp.317~324 (2007)
37. "Randomized controlled open study of sublingual imunotherapy for respiratory alergy in real-life: clinical eficacy and more", 59, pp.1205~1210 (2004)
38. "Efect of specific imunotherapy aded to pharmacologic treatment and alergen avoidance in asthmatic patients allergic to house dust mite", 113, pp.643~649 (2004)

관련 논문AI추천